[Risk factors and adverse outcomes of initial non-invasive ventilation failure in very low birth weight infants: a multicenter retrospective cohort study]

Zhonghua Er Ke Za Zhi. 2024 Dec 2;62(12):1176-1183. doi: 10.3760/cma.j.cn112140-20240513-00326.
[Article in Chinese]

Abstract

Objective: To investigate the risk factors of initial non-invasive ventilation(NIV) failure and its association with adverse outcomes in very low birth weight infants (VLBWI). Methods: A retrospective cohort study was conducted, collecting clinical data of 2 102 VLBWI who received NIV within 30 minutes after birth, admitted to 18 NICU of Suxinyun Neonatal Perinatal Collaboration Network (SNPN) from January 1st, 2019 to December 31st, 2022. According to the outcome of NIV within the first 72 hours, the study cohort was divided into success group and failure group. Univariate analysis and multivariate Logistic regression analysis were performed to identify risk factors for NIV failure and its association with adverse outcome. Results: A total of 2 102 VLBWI were included, consisting of 1 078 males (51.3%). The gestational age was 29 (28, 31) weeks, and the birth weight was 1 250 (1 090, 1 380) g. The initial NIV failure rate was 15.3%(321/2 102). Multivariate Logistic regression analysis showed that smaller gestational age (OR=0.67, 95%CI 0.61-0.74, P<0.001), maternal hypertensive disorders during pregnancy (OR=10.31, 95%CI 7.48-14.21, P<0.001), Apgar score at the first minute ≤7 (OR=1.40, 95%CI 1.01-1.93, P=0.042), grade 3-4 respiratory distress syndrome (RDS)(OR=2.85, 95%CI 1.69-4.81, P<0.001), ≥2 times pulmonary surfactant (PS) treatment (OR=3.78, 95%CI 2.09-6.83, P<0.001), fraction of inspired oxygen (FiO2)>0.30 (OR=2.21, 95%CI 1.64-2.98, P<0.001) were all independent risk factors for initial NIV failure. The failure group had higher risks of mortality (OR=10.19, 95%CI 6.50-15.97, P<0.001), pneumothorax (OR=4.33, 95%CI 1.59-11.79, P=0.004), neonatal pulmonary hemorrhage (OR=8.48, 95%CI 4.08-17.64, P<0.001), moderate to severe bronchopulmonary dysplasia (BPD)(OR=1.75, 95%CI 1.19-2.56, P=0.004), and intraventricular hemorrhage (IVH) ≥grade Ⅲ (OR=2.18, 95%CI 1.27-3.73, P=0.004) compared to the success group. Conclusions: Small gestational age, maternal hyertensive disorders during pregnancy, Apgar score at the first minute ≤7, grade 3-4 RDS, PS treatment ≥2 times and FiO2 >0.30 are risk factors for initial NIV failure in VLBWI. Initial NIV failure is associated with increased risk of mortality, pneumothorax, pulmonary hemorrhage, moderate to severe BPD, and IVH ≥grade Ⅲ.

目的: 探讨极低出生体重儿(VLBWI)初始无创通气失败的危险因素及其与不良结局的关系。 方法: 回顾性队列研究,收集2019年1月1日至2022年12月31日入住苏新云新生儿围产期协作网(SNPN)18家合作单位新生儿重症监护病房生后30 min内即开始使用无创呼吸支持的2 102例VLBWI的临床资料。根据VLBWI生后72 h内无创呼吸支持的结局分为成功组和失败组。采用单因素分析与多因素Logistic回归分析筛选无创通气失败的危险因素,并进一步分析无创通气失败与不良结局的关联。 结果: 2 102例VLBWI中男1 078例(51.3%),出生胎龄29(28,31)周,出生体重1 250(1 090,1 380)g。初始无创通气失败率为15.3%(321/2 102)。多元Logistic回归分析显示,出生胎龄小(OR=0.67,95%CI 0.61~0.74,P<0.001)、母亲妊娠合并高血压疾病(OR=10.31,95%CI 7.48~14.21,P<0.001)、第1分钟Apgar评分≤7分(OR=1.40,95%CI 1.01~1.93,P=0.042)、3~4级呼吸窘迫综合征(OR=2.85,95%CI 1.69~4.81,P<0.001)、肺表面活性物质治疗2次及以上(OR=3.78,95%CI 2.09~6.83,P<0.001)、吸入氧浓度>0.30(OR=2.21,95%CI 1.64~2.98,P<0.001)均为初始无创通气失败的独立危险因素。无创通气失败组患儿死亡(OR=10.19,95%CI 6.50~15.97,P<0.001)、气胸(OR=4.33,95%CI 1.59~11.79,P=0.004)、新生儿肺出血(OR=8.48,95%CI 4.08~17.64,P<0.001)、中重度支气管肺发育不良(OR=1.75,95%CI 1.19~2.56,P=0.004)、Ⅲ级及以上脑室内出血(OR=2.18,95%CI 1.27~3.73,P=0.004)等不良结局的发生风险均高于成功组。 结论: 出生胎龄小、母亲有妊娠高血压疾病、生后第1分钟Apgar评分≤7分、3~4级呼吸窘迫综合征、肺表面活性物质治疗2次及以上、吸入氧浓度>0.30均是VLBWI初始无创通气失败的危险因素。初始无创通气失败与VLBWI死亡、气胸、肺出血、中重度支气管肺发育不良、Ⅲ级及以上脑室内出血等不良结局相关。.

Publication types

  • Multicenter Study
  • English Abstract

MeSH terms

  • Birth Weight
  • Cohort Studies
  • Female
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Infant, Very Low Birth Weight*
  • Intensive Care Units, Neonatal
  • Logistic Models
  • Male
  • Noninvasive Ventilation*
  • Respiratory Distress Syndrome, Newborn* / therapy
  • Retrospective Studies
  • Risk Factors
  • Treatment Failure